{"id":532,"date":"2018-05-30T11:09:10","date_gmt":"2018-05-30T11:09:10","guid":{"rendered":"https:\/\/az.research.umich.edu\/medschool\/glossary\/medschool-glossary-trial-design\/"},"modified":"2024-12-04T21:49:39","modified_gmt":"2024-12-04T21:49:39","slug":"trial-design","status":"publish","type":"glossary","link":"https:\/\/az.research.umich.edu\/medschool\/glossary\/trial-design\/","title":{"rendered":"Trial Design"},"template":"","class_list":["post-532","glossary","type-glossary","status-publish","hentry"],"acf":{"glossary_term_description":"Some Phase II trials are designed as\u00a0<a href=\"http:\/\/en.wikipedia.org\/wiki\/Case_series\">case series<\/a>, demonstrating a drug's safety and activity in a selected group of patients. Other Phase II trials are designed as\u00a0<a href=\"http:\/\/en.wikipedia.org\/wiki\/Randomized_clinical_trial\">randomized clinical trials<\/a>, where some patients receive the drug\/device and others receive placebo\/standard treatment. Randomized Phase II trials have far fewer patients than randomized Phase III trials.","glossary_related_terms":"","legacy_glossary_node_id":773,"legacy_related_terms":""},"_links":{"self":[{"href":"https:\/\/az.research.umich.edu\/medschool\/wp-json\/wp\/v2\/glossary\/532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/az.research.umich.edu\/medschool\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/az.research.umich.edu\/medschool\/wp-json\/wp\/v2\/types\/glossary"}],"wp:attachment":[{"href":"https:\/\/az.research.umich.edu\/medschool\/wp-json\/wp\/v2\/media?parent=532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}